Microsoft to Lay Off 3% of Global Workforce
May 14, 2025: Microsoft has announced plans to reduce its global workforce by approximately 3%, affecting roughly 10,000 employees across multiple departments.
- May 20, 2025 12:11 pm
- California
December 15, 2021: -U.S. drugmaker Moderna will produce millions of mRNA vaccines a year in Australia after agreeing to set up one of its most extensive manufacturing facilities outside the United States and Europe.
The deal, a second such commitment in the Asia Pacific by a western mRNA vaccine developer, underscores efforts by governments worldwide to build up local production and prepare for future pandemic threats after limited early access to shots led to slow Covid-19 vaccine rollouts.
Australian Prime Minister Scott Morrison said the plant in Victoria state was expected to produce up to 100 million mRNA vaccine doses every year when it started operations in 2024.
“By advancing with this partnership, we are building our sovereign capability to manufacture these vaccines here in Australia,” Morrison told reporters in Melbourne.
Morrison did not clearly say the financial details of the agreement, but Australian media reported the deal could be worth nearly A$2 billion ($1.43 billion).
In October, Moderna said that it planned to invest up to $500 million to build a factory in Africa to make up to 500 million doses of mRNA vaccines each year, which include its Covid-19 dose.
Covid-19 vaccines developed by Moderna and Pfizer-BioNTech use mRNA messenger ribonucleic acid, which teaches cells how to make a protein that triggers an immune response. The technology can also manufacture vaccines for other respiratory illnesses and seasonal flu.
BioNTech announced a plan in May to set up a new factory in Singapore with an estimated annual capacity of several hundred million doses of its mRNA vaccines once it is operational in 2023.
South Korea, which has a deal with Moderna to provide bottling work for the U.S. firm’s Covid-19 vaccine, also seeks to attract mRNA vaccine makers to start local production.
The announcement by Moderna was made as Australia’s New South Wales state, home to Sydney, reported its most significant daily rise in Covid-19 cases since a nearly four-month lockdown ended in early October.
Despite the surge in new infections, officials said a planned easing of restrictions in Sydney from Wednesday would proceed as they urged people to get their booster shots to ward off the omicron threat.
We provide the insights on leaders who are responsible for taking their organization to new heights, all the while bringing together a group of talented individuals.
May 14, 2025: Microsoft has announced plans to reduce its global workforce by approximately 3%, affecting roughly 10,000 employees across multiple departments.
May 13, 2025: The Trump administration is considering suspending the constitutional right of habeas corpus in a bid to accelerate mass deportations.
April 29, 2025: Donald Trump’s second term has reached the 100-day mark under sustained public skepticism, with national approval ratings
April 24, 2025: NATO closely monitors a series of Russian naval exercises in the northern waters near Finland and Norway amid heightened military activity
April 23, 2025: The U.S. Supreme Court is preparing to issue a ruling on whether AI-generated political speech is protected under the First Amendment
Manufacturers often struggle with generating accurate and timely quotes, delaying customer responses and risking profitability. Traditional quoting processes can take days or even weeks, while customers expect responses within 24 hours. Micro Estimating Systems addresses these challenges with advanced software that allows users to generate highly accurate quotes in minutes. By integrating with shop-specific data and automating feature recognition, their solutions ensure precision and speed, empowering manufacturers to make informed decisions and enhance their operational efficiency.